This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Exploring the Early VERITAS Results of Abbott’s Amulet Dual-Seal LAA Occluder for Stroke Prevention in Atrial Fibrillation Patients Unsuitable for Anticoagulation

Ticker(s): ABT, BSX

Who's the expert?

Institution: Mount Sinai

  • Cardiac electrophysiologist and Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai Hospital.
  • Performs 200 Left Atrial Appendage closure procedures  per year and implants pacemakers for the treatment of bradycardia over 500 times per year.
  • Has authored over 200-peer reviewed scientific publications mainly focused in arrhythmia care.

 

Interview Goal
Gain a deeper understanding of Abbott’s Amulet Dual-Seal LAA Occluder and how it can impact the space for AF patients unsuitable for anticoagulation.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.